Medipol Mega University Hospital Performs Turkey’s First G5 MitraClip Procedure

Medipol Mega University Hospital Initiates Turkey’s First G5 MitraClip Procedure

The procedure, designed for patients with advanced mitral and tricuspid valve insufficiency who are ineligible for open-heart surgery, aims to improve treatment success and patient quality of life. The implementation of the G5 MitraClip technology represents a significant shift for patients previously deemed unsuitable for traditional surgical interventions.

The technology, often referred to as the mandallama yöntemi (clamping method) by the public, focuses on reducing leaks in heart valves to enhance overall patient outcomes.

Clinical Objectives and Technological Advancements

Prof. Dr. Bilal Boztosun Deploys G5 System for Mitral and Tricuspid Valve Patients

Prof. Dr. Bilal Boztosun, a Cardiology Specialist at Medipol Health Group, emphasized that the primary motivation behind adopting the G5 system is to provide immediate access to global medical advancements. Amacımız dünyadaki en son teknolojiyi ülkemizdeki hastalarla buluşturmak. G5 teknolojisini Türkiye’de ilk kullanan merkez olmanın gururunu yaşıyoruz, said Prof. Dr. Boztosun. He noted that the new-generation technology offers distinct advantages for the treatment of severe mitral and tricuspid valve issues.

The Medipol cardiology team believes these advancements improve both the immediate success of procedures and long-term patient compliance. Prof. Dr. Boztosun stated, “Medipol Kardiyoloji ailesi olarak dünya standartlarındaki yenilikleri yakından takip ediyor ve hastalarımıza en güncel tedavi seçeneklerini sunmaya çalışıyoruz. Yeni nesil teknolojiler sayesinde hem işlem başarımız hem de uzun dönem hasta uyumu daha da artıyor.”

Patient Eligibility and Alternative Treatment Pathways

MitraClip Method Offers High-Risk Patients an Alternative to Open-Heart Surgery

While open-heart surgery remains the gold standard for treating heart valve diseases, the MitraClip method serves as a critical alternative for high-risk patients. Prof. Dr. Boztosun explained that the procedure is specifically indicated for those with advanced valve insufficiency who cannot undergo surgery due to co-existing medical conditions. By utilizing the clamping mechanism, physicians can reduce regurgitation, directly impacting the patient’s daily comfort.

İleri derecede mitral kapak ve triküspit kapak yetersizliği bulunan, eşlik eden hastalıkları nedeniyle cerrahi şansı olmayan hastalarda bu yöntemi başarıyla uyguluyoruz, Prof. Dr. Boztosun noted. Cerrahi hâlâ altın standart tedavi yöntemidir ancak uygun olmayan hastalar için bu teknoloji güçlü bir alternatif sunuyor.

Integration of Expertise and Modern Tools

Medipol Cardiology Team Combines Junior Energy and Senior Experience for G5 Interventions

Success in these complex interventions relies on more than just the hardware. The clinical team at Medipol combines the energy of younger physicians with the established experience of senior staff.

Medipol Mega University Hospital / İstanbul, Turkey

Genç hekimlerin enerjisini, deneyimli ekibimizin bilgi birikimiyle birleştirerek hastalarımıza en iyi hizmeti vermeyi hedefliyoruz, Prof. Dr. Boztosun

Readers interested in learning more about whether these interventional procedures are appropriate for specific health conditions should consult with qualified medical professionals. Medical decisions regarding heart valve treatment must be made based on an individual’s specific clinical history and current health status.

Worth a look


Discover more from Archyworldys

Subscribe to get the latest posts sent to your email.